Syvertsen MR - Search Results

1

Clinical heterogeneity of juvenile myoclonic epilepsy: follow-up after an interval of more than 20 years.

Syvertsen MR, Thuve S, Stordrange BS, Brodtkorb E. Syvertsen MR, et al. Seizure. 2014 May;23(5):344-8. doi: 10.1016/j.seizure.2014.01.012. Epub 2014 Jan 23. Seizure. 2014. PMID: 24512779 Free article.

2

Headaches add to the burden of epilepsy.

Syvertsen M, Helde G, Stovner LJ, Brodtkorb E. Syvertsen M, et al. J Headache Pain. 2007 Sep;8(4):224-30. doi: 10.1007/s10194-007-0398-3. Epub 2007 Sep 24. J Headache Pain. 2007. PMID: 17901922 Free PMC article.

3

[Juvenile myoclonic epilepsy].

Syvertsen MR, Markhus R, Selmer KK, Nakken KO. Syvertsen MR, et al. Tidsskr Nor Laegeforen. 2012 Aug 7;132(14):1610-3. doi: 10.4045/tidsskr.11.1518. Tidsskr Nor Laegeforen. 2012. PMID: 22875125 Free article. Review. Norwegian.

4

Prevalence of juvenile myoclonic epilepsy in people <30 years of age-A population-based study in Norway.

Syvertsen M, Hellum MK, Hansen G, Edland A, Nakken KO, Selmer KK, Koht J. Syvertsen M, et al. Epilepsia. 2017 Jan;58(1):105-112. doi: 10.1111/epi.13613. Epub 2016 Nov 16. Epilepsia. 2017. PMID: 27861775 Free article.

5

Prolonged epileptiform EEG runs are associated with persistent seizures in juvenile myoclonic epilepsy.

Arntsen V, Sand T, Syvertsen MR, Brodtkorb E. Arntsen V, et al. Among authors: syvertsen mr. Epilepsy Res. 2017 Aug;134:26-32. doi: 10.1016/j.eplepsyres.2017.05.003. Epub 2017 May 8. Epilepsy Res. 2017. PMID: 28527369

6

Antiepileptic drug withdrawal in juvenile myoclonic epilepsy.

Syvertsen M, Fløgstad I, Enger U, Landmark CJ, Koht J. Syvertsen M, et al. Acta Neurol Scand. 2019 Feb;139(2):192-198. doi: 10.1111/ane.13042. Epub 2018 Nov 15. Acta Neurol Scand. 2019. PMID: 30378684

7

Psychosocial complications in juvenile myoclonic epilepsy.

Syvertsen M, Selmer K, Enger U, Nakken KO, Pal DK, Smith A, Koht J. Syvertsen M, et al. Epilepsy Behav. 2019 Jan;90:122-128. doi: 10.1016/j.yebeh.2018.11.022. Epub 2019 Jan 22. Epilepsy Behav. 2019. PMID: 30530133

8

Long-term follow-up with therapeutic drug monitoring of antiepileptic drugs in patients with juvenile myoclonic epilepsy.

Johannessen Landmark C, Fløgstad I, Baftiu A, Syvertsen M, Enger U, Koht J, Johannessen SI. Johannessen Landmark C, et al. Epilepsy Res. 2019 Sep;155:106148. doi: 10.1016/j.eplepsyres.2019.05.016. Epub 2019 May 30. Epilepsy Res. 2019. PMID: 31195184 Free article.

9

Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy.

Johannessen Landmark C, Fløgstad I, Syvertsen M, Baftiu A, Enger U, Koht J, Johannessen SI. Johannessen Landmark C, et al. Epilepsy Behav. 2019 Sep;98(Pt A):110-116. doi: 10.1016/j.yebeh.2019.05.021. Epub 2019 Jul 19. Epilepsy Behav. 2019. PMID: 31330379 Free article.

10

Meta-analysis of response inhibition in juvenile myoclonic epilepsy.

Smith A, Syvertsen M, Pal DK. Smith A, et al. Epilepsy Behav. 2020 May;106:107038. doi: 10.1016/j.yebeh.2020.107038. Epub 2020 Mar 30. Epilepsy Behav. 2020. PMID: 32240946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page